Style | Citing Format |
---|---|
MLA | Keshvari A, et al.. "Preoperative Carcinoembryonic Antigen As a Predictor of 5-Year Survival in Rectal Cancer: Proposing a New Prognostic Cutoff." Journal of Gastrointestinal Cancer, vol. 56, no. 1, 2025, pp. -. |
APA | Keshvari A, Tafti SMA, Keramati MR, Fazeli MS, Kazemeini A, Behboudi B, Asbagh RA, Mirzasadeghi A (2025). Preoperative Carcinoembryonic Antigen As a Predictor of 5-Year Survival in Rectal Cancer: Proposing a New Prognostic Cutoff. Journal of Gastrointestinal Cancer, 56(1), -. |
Chicago | Keshvari A, Tafti SMA, Keramati MR, Fazeli MS, Kazemeini A, Behboudi B, Asbagh RA, Mirzasadeghi A. "Preoperative Carcinoembryonic Antigen As a Predictor of 5-Year Survival in Rectal Cancer: Proposing a New Prognostic Cutoff." Journal of Gastrointestinal Cancer 56, no. 1 (2025): -. |
Harvard | Keshvari A et al. (2025) 'Preoperative Carcinoembryonic Antigen As a Predictor of 5-Year Survival in Rectal Cancer: Proposing a New Prognostic Cutoff', Journal of Gastrointestinal Cancer, 56(1), pp. -. |
Vancouver | Keshvari A, Tafti SMA, Keramati MR, Fazeli MS, Kazemeini A, Behboudi B, et al.. Preoperative Carcinoembryonic Antigen As a Predictor of 5-Year Survival in Rectal Cancer: Proposing a New Prognostic Cutoff. Journal of Gastrointestinal Cancer. 2025;56(1):-. |
BibTex | @article{ author = {Keshvari A and Tafti SMA and Keramati MR and Fazeli MS and Kazemeini A and Behboudi B and Asbagh RA and Mirzasadeghi A}, title = {Preoperative Carcinoembryonic Antigen As a Predictor of 5-Year Survival in Rectal Cancer: Proposing a New Prognostic Cutoff}, journal = {Journal of Gastrointestinal Cancer}, volume = {56}, number = {1}, pages = {-}, year = {2025} } |
RIS | TY - JOUR AU - Keshvari A AU - Tafti SMA AU - Keramati MR AU - Fazeli MS AU - Kazemeini A AU - Behboudi B AU - Asbagh RA AU - Mirzasadeghi A TI - Preoperative Carcinoembryonic Antigen As a Predictor of 5-Year Survival in Rectal Cancer: Proposing a New Prognostic Cutoff JO - Journal of Gastrointestinal Cancer VL - 56 IS - 1 SP - EP - PY - 2025 ER - |